- Home
- PHAT vs HQH Comparison
PHAT vs HQH Comparison
Compare PHAT & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- HQH
- Stock Information
- Founded
- PHAT 2018
- HQH 1986
- Country
- PHAT United States
- HQH United States
- Employees
- PHAT N/A
- HQH N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- HQH Finance Companies
- Sector
- PHAT Health Care
- HQH Finance
- Exchange
- PHAT Nasdaq
- HQH Nasdaq
- Market Cap
- PHAT 769.0M
- HQH 890.9M
- IPO Year
- PHAT 2019
- HQH N/A
- Fundamental
- Price
- PHAT $13.55
- HQH $19.69
- Analyst Decision
- PHAT Strong Buy
- HQH
- Analyst Count
- PHAT 5
- HQH 0
- Target Price
- PHAT $17.60
- HQH N/A
- AVG Volume (30 Days)
- PHAT 1.3M
- HQH 183.8K
- Earning Date
- PHAT 10-30-2025
- HQH 01-01-0001
- Dividend Yield
- PHAT N/A
- HQH 11.56%
- EPS Growth
- PHAT N/A
- HQH N/A
- EPS
- PHAT N/A
- HQH 1.09
- Revenue
- PHAT $147,190,000.00
- HQH N/A
- Revenue This Year
- PHAT $213.65
- HQH N/A
- Revenue Next Year
- PHAT $91.41
- HQH N/A
- P/E Ratio
- PHAT N/A
- HQH $15.24
- Revenue Growth
- PHAT 460.30
- HQH N/A
- 52 Week Low
- PHAT $2.21
- HQH $14.31
- 52 Week High
- PHAT $19.50
- HQH $17.94
- Technical
- Relative Strength Index (RSI)
- PHAT 58.66
- HQH 70.70
- Support Level
- PHAT $13.02
- HQH $19.22
- Resistance Level
- PHAT $16.08
- HQH $19.63
- Average True Range (ATR)
- PHAT 1.05
- HQH 0.31
- MACD
- PHAT -0.02
- HQH -0.01
- Stochastic Oscillator
- PHAT 44.88
- HQH 100.00
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About HQH abrdn Healthcare Investors Shares of Beneficial Interest
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.